Delivery Order SPE2DB22D2006-SPE2DB24FW2JG

Award Date 7/31/24
Potential Completion Date 8/1/24
Potential Value $36K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,935.62, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of February 3, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,064.20, is for the delivery of 4564590417 Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of May 14, 2024 and is a firm fixed-price contract. This award is not associated with a set-aside program. AmerisourceBergen holds a larger...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,156.16, is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of March 12, 2025 and is a Firm Fixed Price Delivery Order. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,596.20, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of May 23, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,489.90, is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The contract is a firm fixed-price delivery order with a completion date of March 14, 2025. This contract is not designated as a set-aside. AmerisourceBergen also holds a larger Indefinite Delivery Contract (IDC)...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $20,808.22 and is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of December 6, 2024. This contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,171.84, is for the delivery of 4,568,189,942 units of the medication Losartan-HCTZ 100-25 mg tablets. The contract has a completion date of May 9, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of losartan-HCTZ 100-12.5 mg tablets. The contract has a ceiling value of $7,409.12 and a period of performance through September 10, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, will provide these prescription medications to support military treatment facilities and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,153.53, is for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has an ultimate completion date of February 13, 2025 and is a firm fixed-price type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,513.08, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as a primary vehicle for providing...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB24FW2JG
    Delivery Order

This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of August 1, 2024 and a ceiling value of $36,216.38. The contract is not associated with any set-aside program. As a major pharmaceutical distributor, Amerisourcebergen has been awarded numerous federal contracts by the DLA and other agencies to provide a wide range of prescription medications, medical supplies, and critical care materials to support military treatment facilities, veterans' hospitals, and other federal healthcare providers. This specific delivery order is part of Amerisourcebergen's Indefinite Delivery Contract with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for the company to supply pharmaceutical and medical products to the U.S. federal government.

Generated 10/30/24, 9:17 AM